Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO®
Eton Pharmaceuticals relaunches HEMANGEOL® Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® Oral Solution
Eton Pharmaceuticals to Participate at Leerink Partners Global Healthcare Conference on Wednesday, March 11th
Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th
Juggernaut Mobilizes For Inaugural 10,000 Meter Drill Program to Test New District Scale High Grade Gold Silver Copper Rich Discovery at 100% Controlled Big One Property, Golden Triangle, B.C
Prince Reports 27.43 Metres Grading 93.7 g/t Silver, 12.0% Mn, 2.29% Pb and 2.48% Zn at Its Prince Silver Project in Nevada;
Market One: Standard Uranium Ltd. Prepares to Drill Its Flagship Davidson River Uranium Project in Saskatchewan's Athabasca Basin
